Faknostics, LLC

Funding and NIH signals

• NIH award NIH awarded $663K (STTR Phase II 5R42HL162392-04, continuation, notice Sep 4, 2026); 2 NIH awards totaling $1.33M in the last 12 months. NIH RePORTER 5R42HL162392-04 (Sep 4, 2026)
  Evidence (2 events)

  • Sep 4, 2026 · NIH RePORTER 5R42HL162392-04
    Organization: FAKNOSTICS, LLC; City/State: PHOENIX, AZ; Project number: 5R42HL162392-04; Activity code: R42; Fiscal year: 2026; Award notice date: 2026-09-04; FY total cost (award amount): 662561; Administering IC: National Heart Lung and Blood Institute; Project title: Non-catalytic FAK inhibitors as novel therapeutics for lung fibrosis; Organization type: Domestic For-Profits
  • Aug 3, 2026 · NIH RePORTER 5R42DK141379-03
    Organization: FAKNOSTICS, LLC; City/State: PHOENIX, AZ; Project number: 5R42DK141379-03; Activity code: R42; Fiscal year: 2026; Award notice date: 2026-08-03; FY total cost (award amount): 669464; Administering IC: National Institute of Diabetes and Digestive and Kidney Diseases; Project title: Novel Paxillin-FAK Inhibitors for the Treatment of Liver Fibrosis; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals